BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28941255)

  • 1. Effects of placebo-controlled insulin-sensitizing drugs on hormonal parameters in polycystic ovary syndrome patients: A network meta-analysis.
    Huang R; Zhao PF; Xu JH; Liu DD; Luo FD; Dai YH
    J Cell Biochem; 2018 Mar; 119(3):2501-2511. PubMed ID: 28941255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women With PCOS.
    Xing C; Li C; He B
    J Clin Endocrinol Metab; 2020 Sep; 105(9):2950-63. PubMed ID: 32490533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
    Abdel-Maboud M; Menshawy A; Hasabo EA; Abdelraoof MI; Alshandidy M; Eid M; Menshawy E; Outani O; Menshawy A
    PLoS One; 2021; 16(7):e0254412. PubMed ID: 34280195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis.
    Barba M; Schünemann HJ; Sperati F; Akl EA; Musicco F; Guyatt G; Muti P
    Clin Endocrinol (Oxf); 2009 May; 70(5):661-70. PubMed ID: 19178532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and glitazones: do they really help PCOS patients?
    Pillai A; Bang H; Green C
    J Fam Pract; 2007 Jun; 56(6):444-53. PubMed ID: 17543254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
    Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
    Arch Gynecol Obstet; 2023 May; 307(5):1347-1376. PubMed ID: 35434762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
    Lord JM; Flight IH; Norman RJ
    Cochrane Database Syst Rev; 2003; (3):CD003053. PubMed ID: 12917943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Thiazolidinediones in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
    Adv Ther; 2024 Jun; 41(6):2168-2195. PubMed ID: 38683294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome.
    Rouzi AA; Ardawi MS
    Fertil Steril; 2006 Feb; 85(2):428-35. PubMed ID: 16595222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of omega-3 polyunsaturated fatty acids on hormones, oxidative stress, and inflammatory parameters among polycystic ovary syndrome: a systematic review and meta-analysis.
    Yuan J; Wen X; Jia M
    Ann Palliat Med; 2021 Aug; 10(8):8991-9001. PubMed ID: 34488386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of metformin, oral contraceptives, and lifestyle modification in improving the metabolism of overweight women with polycystic ovary syndrome: a network meta-analysis.
    Wang A; Mo T; Li Q; Shen C; Liu M
    Endocrine; 2019 May; 64(2):220-232. PubMed ID: 30911997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.
    Baillargeon JP; Jakubowicz DJ; Iuorno MJ; Jakubowicz S; Nestler JE
    Fertil Steril; 2004 Oct; 82(4):893-902. PubMed ID: 15482765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.
    Patel R; Shah G
    Curr Med Res Opin; 2017 Sep; 33(9):1545-1557. PubMed ID: 28058854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.
    Costello M; Shrestha B; Eden J; Sjoblom P; Johnson N
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005552. PubMed ID: 17253562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].
    Ye BL; Yang HY; Zhao JZ; Lin JJ; Lin WQ
    Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):745-8. PubMed ID: 14728846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials.
    Sheth SH; Larson RJ
    BMC Infect Dis; 2010 Jun; 10():183. PubMed ID: 20573187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different drug for reducing testosterone levels in women with polycystic ovary syndrome: A systematic review and network meta-analysis.
    Hao SL; Zhang CL; Meng XY
    Medicine (Baltimore); 2023 Oct; 102(41):e35152. PubMed ID: 37832133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
    Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
    Chou KH; von Eye Corleta H; Capp E; Spritzer PM
    Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.